PSDV - Eyepoint Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Laboratory Analytical Instruments - PSDV (1314102)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
29 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-02-02
EYPTJones David ScottSVP, Chief Commercial OfficerS - Sale+OE$28.49-20937,962-1%-$5,954
D
2024-01-26
EYPTPaggiarino Dario A.Chief Medical OfficerS - Sale+OE$25.66-49,32536,505-57%-$1,265,539
D
2024-01-26
EYPTJones David ScottSVP, Chief Commercial OfficerS - Sale+OE$25.38-26,01737,962-41%-$660,370
D
2024-01-25
EYPTPaggiarino Dario A.Chief Medical OfficerS - Sale+OE$25.00-60036,505-2%-$15,000
DM
2024-01-24
EYPTJones David ScottSVP, Chief Commercial OfficerS - Sale+OE$25.01-11,90037,962-24%-$297,621
DM
2024-01-23
EYPTPaggiarino Dario A.Chief Medical OfficerS - Sale+OE$25.01-16,38636,505-31%-$409,790
DM
2024-01-23
EYPTLurker NancyExec Vice ChairS - Sale+OE$24.98-35,000187,649-16%-$874,200
DM
2024-01-22
EYPTJones David ScottSVP, Chief Commercial OfficerS - Sale+OE$22.68-35,06637,962-48%-$795,191
2024-01-11
EYEPOcumension TherapeuticsDirS - Sale$19.45-1,910,500100,221-95%-$37,159,225
2024-01-11
EYPTLiu YeDirS - Sale$19.45-1,910,500100,221-95%-$37,159,225
M
2024-01-09
EYPTCormorant Asset Management, LP10%P - Purchase$19.94+855,0006,893,235+14%+$17,051,100
D
2024-01-08
EYPTPaggiarino Dario A.Chief Medical OfficerS - Sale+OE$21.13-22,91336,505-39%-$484,124
D
2023-12-13
EYPTPaggiarino Dario A.Chief Medical OfficerS - Sale+OE$20.00-1,45825,707-5%-$29,160
2023-12-08
EYPTCormorant Asset Management, LP10%P - Purchase$17.00+588,2356,038,235+11%+$9,999,995
AD
2023-12-04
EYPTPine Michael CraigChief Corp Dev., Strat. OfficeS - Sale+OE$21.97-46,0004,343-91%-$1,010,790
M
2023-12-05
EYEPOcumension TherapeuticsDirS - Sale$19.51-1,000,0002,010,721-33%-$19,510,637
M
2023-12-05
EYPTLiu YeDirS - Sale$19.51-1,000,0002,010,721-33%-$19,510,637
D
2023-12-04
EYPTPine Michael CraigChief Corp Dev., Strat. OfficeS - Sale+OE$22.00-45,0005,343-89%-$990,000
D
2023-12-04
EYPTPaggiarino Dario A.Chief Medical OfficerS - Sale+OE$22.00-30,62525,707-54%-$673,750
2023-12-04
EYPTLurker NancyExec Vice ChairS - Sale$20.76-20,000170,559-10%-$415,200
2023-12-04
EYPTCormorant Asset Management, LP10%P - Purchase$21.82+1,919,0575,450,000+54%+$41,874,151
A
2023-09-01
EYPTEw Healthcare Partners, L.P.See footnotes 1 and 3, 10%S - Sale$9.90-20,0003,490,921-1%-$197,982
2023-09-01
EYPTEw Healthcare Partners, L.P.See footnotes 1 and 3, 10%S - Sale$9.90-20,0003,490,921-1%-$197,982
M
2023-08-30
EYPTEw Healthcare Partners, L.P.See footnotes 1 and 6, 10%S - Sale$10.54-139,4713,510,921-4%-$1,470,208
M
2023-08-28
EYPTEw Healthcare Partners, L.P.See footnotes 1 and 4, 10%S - Sale$11.14-148,7123,650,392-4%-$1,656,878
AM
2023-08-24
EYPTEw Healthcare Partners, L.P.See footnotes 1 and 6, 10%S - Sale$11.11-223,9363,799,104-6%-$2,487,482
M
2023-08-24
EYPTEw Healthcare Partners, L.P.See footnotes 1 and 2, 10%S - Sale$13.25-223,9363,799,104-6%-$2,967,572
M
2023-08-22
EYPTEw Healthcare Partners, L.P.See footnotes 1 and 2, 10%S - Sale$13.49-167,8814,023,040-4%-$2,264,748
2023-05-30
EYPTLiu YeDirS - Sale$6.00-13,010,7210%-$6

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top